Home > Balance Sheet > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Sundry Debtors

    Back to Balance Sheet
BAFNA PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year Sundry Debtors History

[Standalone]

Mar2023Mar2022Mar2021Mar2020Mar2019
Sundry Debtors ₹41 Cr₹15 Cr₹9.56 Cr₹6.04 Cr₹25 Cr

What is the latest Sundry Debtors ratio of BAFNA PHARMACEUTICALS ?

The latest Sundry Debtors ratio of BAFNA PHARMACEUTICALS is ₹41 Cr based on Mar2023 Standalone results.
Year Sundry Debtors
Mar2023₹41 Cr
Mar2022₹15 Cr
Mar2021₹9.56 Cr
Mar2020₹6.04 Cr
Mar2019₹25 Cr

How is Sundry Debtors of BAFNA PHARMACEUTICALS Trending?

Years Sundry Debtors % Change
Mar2023 ₹41 Cr
178.41
Mar2022 ₹15 Cr
54.60
Mar2021 ₹9.56 Cr
58.41
Mar2020 ₹6.04 Cr
-75.70
Mar2019 ₹25 Cr -

Compare Sundry Debtors of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹253.0 Cr 21.6% 39.2% -0.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹361,916.0 Cr 0.3% -7.5% 53.9% Stock Analytics
CIPLA ₹115,034.0 Cr 1.1% -4.8% 56.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,929.0 Cr 1.6% 1.6% 27.6% Stock Analytics
DIVIS LABORATORIES ₹104,873.0 Cr -1.9% 10.7% 21.4% Stock Analytics
ZYDUS LIFESCIENCES ₹100,322.0 Cr 5.2% -0.2% 90.1% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

21.6%

39.2%

-0.2%

SENSEX

-0.6%

0.3%

21.8%


You may also like the below Video Courses